Literature DB >> 35851375

Engineering circular RNA for enhanced protein production.

Robert Chen1, Sean K Wang1,2, Julia A Belk3, Laura Amaya1, Zhijian Li4, Angel Cardenas1, Brian T Abe1, Chun-Kan Chen1, Paul A Wender4,5, Howard Y Chang6,7.   

Abstract

Circular RNAs (circRNAs) are stable and prevalent RNAs in eukaryotic cells that arise from back-splicing. Synthetic circRNAs and some endogenous circRNAs can encode proteins, raising the promise of circRNA as a platform for gene expression. In this study, we developed a systematic approach for rapid assembly and testing of features that affect protein production from synthetic circRNAs. To maximize circRNA translation, we optimized five elements: vector topology, 5' and 3' untranslated regions, internal ribosome entry sites and synthetic aptamers recruiting translation initiation machinery. Together, these design principles improve circRNA protein yields by several hundred-fold, provide increased translation over messenger RNA in vitro, provide more durable translation in vivo and are generalizable across multiple transgenes.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35851375     DOI: 10.1038/s41587-022-01393-0

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


  53 in total

1.  Enzymatic assembly of DNA molecules up to several hundred kilobases.

Authors:  Daniel G Gibson; Lei Young; Ray-Yuan Chuang; J Craig Venter; Clyde A Hutchison; Hamilton O Smith
Journal:  Nat Methods       Date:  2009-04-12       Impact factor: 28.547

2.  Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs.

Authors:  C Y Chen; P Sarnow
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

3.  Sensing Self and Foreign Circular RNAs by Intron Identity.

Authors:  Y Grace Chen; Myoungjoo V Kim; Xingqi Chen; Pedro J Batista; Saeko Aoyama; Jeremy E Wilusz; Akiko Iwasaki; Howard Y Chang
Journal:  Mol Cell       Date:  2017-06-15       Impact factor: 17.970

Review 4.  The mechanism of eukaryotic translation initiation and principles of its regulation.

Authors:  Richard J Jackson; Christopher U T Hellen; Tatyana V Pestova
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02       Impact factor: 94.444

Review 5.  The design and synthesis of circular RNAs.

Authors:  Prisca Obi; Y Grace Chen
Journal:  Methods       Date:  2021-03-02       Impact factor: 3.608

6.  Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate.

Authors:  Mary P Hall; James Unch; Brock F Binkowski; Michael P Valley; Braeden L Butler; Monika G Wood; Paul Otto; Kristopher Zimmerman; Gediminas Vidugiris; Thomas Machleidt; Matthew B Robers; Hélène A Benink; Christopher T Eggers; Michael R Slater; Poncho L Meisenheimer; Dieter H Klaubert; Frank Fan; Lance P Encell; Keith V Wood
Journal:  ACS Chem Biol       Date:  2012-08-30       Impact factor: 5.100

7.  Engineering circular RNA for potent and stable translation in eukaryotic cells.

Authors:  R Alexander Wesselhoeft; Piotr S Kowalski; Daniel G Anderson
Journal:  Nat Commun       Date:  2018-07-06       Impact factor: 14.919

8.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

9.  A one pot, one step, precision cloning method with high throughput capability.

Authors:  Carola Engler; Romy Kandzia; Sylvestre Marillonnet
Journal:  PLoS One       Date:  2008-11-05       Impact factor: 3.240

10.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

Authors:  Edward E Walsh; Robert W Frenck; Ann R Falsey; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; Kathleen Neuzil; Mark J Mulligan; Ruth Bailey; Kena A Swanson; Ping Li; Kenneth Koury; Warren Kalina; David Cooper; Camila Fontes-Garfias; Pei-Yong Shi; Özlem Türeci; Kristin R Tompkins; Kirsten E Lyke; Vanessa Raabe; Philip R Dormitzer; Kathrin U Jansen; Uğur Şahin; William C Gruber
Journal:  N Engl J Med       Date:  2020-10-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.